110 related articles for article (PubMed ID: 3338663)
1. Complications of Tenckhoff catheter implantation in patients with multiple previous intraabdominal procedures for ovarian carcinoma.
de Graaf PW; Mellema MM; ten Bokkel Huinink WW; Aartsen EJ; Dubbelman R; Franklin HR; Hart AA
Gynecol Oncol; 1988 Jan; 29(1):43-9. PubMed ID: 3338663
[TBL] [Abstract][Full Text] [Related]
2. Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma.
Sakuragi N; Nakajima A; Nomura E; Noro N; Yamada H; Yamamoto R; Fujimoto S
Gynecol Oncol; 2000 Dec; 79(3):420-3. PubMed ID: 11104613
[TBL] [Abstract][Full Text] [Related]
3. Preliminary experience with a modified Tenckhoff catheter for intraperitoneal chemotherapy.
Nguyen HN; Averette HE; Wyble L; Sevin BU; Donato D; Penalver M
J Surg Oncol; 1993 Apr; 52(4):237-40. PubMed ID: 8468986
[TBL] [Abstract][Full Text] [Related]
4. [Surgical complications connected with intraperitoneal chemotherapy in ovarian cancer].
Milczek T; Emerich J; Klasa-Mazurkiewicz D
Ginekol Pol; 2003 Sep; 74(9):817-23. PubMed ID: 14674130
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal cisplatin-based chemotherapy vs. intravenous cisplatin-based chemotherapy for stage III optimally cytoreduced epithelial ovarian cancer.
Yen MS; Juang CM; Lai CR; Chao GC; Ng HT; Yuan CC
Int J Gynaecol Obstet; 2001 Jan; 72(1):55-60. PubMed ID: 11146078
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of surgical complications connected with intraperitoneal chemotherapy in ovarian cancer].
Emerich J; Milczek T; Debniak J; Majdak E
Ginekol Pol; 2002 Nov; 73(11):1103-8. PubMed ID: 12722406
[TBL] [Abstract][Full Text] [Related]
7. Toxicities, complications, and clinical encounters during intraperitoneal chemotherapy in 17 women with ovarian cancer.
Sun V; Otis-Green S; Morgan R; Wakabayashi M; Hakim A; Callado ME; Yang E; Ferrell B; Grant M
Eur J Oncol Nurs; 2013 Jun; 17(3):375-80. PubMed ID: 23153453
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic placement of PAP catheters for intraperitoneal chemotherapy in ovarian carcinoma.
Arts HJ; Willemse PH; Tinga DJ; de Vries EG; van der Zee AG
Gynecol Oncol; 1998 Apr; 69(1):32-5. PubMed ID: 9570995
[TBL] [Abstract][Full Text] [Related]
9. Complications associated with intraperitoneal chemotherapy catheters.
Makhija S; Leitao M; Sabbatini P; Bellin N; Almadrones L; Leon L; Spriggs DR; Barakat R
Gynecol Oncol; 2001 Apr; 81(1):77-81. PubMed ID: 11277654
[TBL] [Abstract][Full Text] [Related]
10. It's not just for laparoscopy anymore: use of insufflation under ultrasound and fluoroscopic guidance by Interventional Radiologists for percutaneous placement of intraperitoneal chemotherapy catheters.
Henretta MS; Anderson CL; Angle JF; Duska LR
Gynecol Oncol; 2011 Nov; 123(2):342-5. PubMed ID: 21840583
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of grade 3/4 toxicity associated with intraperitoneal chemotherapy administered after primary versus interval surgical debulking in ovarian cancer.
Le T; Latifah H; Jolicoeur L; Faught W; Weberpals J; Hopkins L; Fung-Kee-Fung M
Int J Gynecol Cancer; 2011 Jul; 21(5):811-5. PubMed ID: 21412160
[TBL] [Abstract][Full Text] [Related]
12. Technique of intraperitoneal chemotherapy using veress needle in patients with ovarian cancer.
Ramarajapalli ML; Kilara NG; Subramanyam M; Rao NA
Int J Gynecol Cancer; 2011 Nov; 21(8):1388-90. PubMed ID: 21997168
[TBL] [Abstract][Full Text] [Related]
13. Catheter complications associated with intraperitoneal chemotherapy.
Runowicz CD; Dottino PR; Shafir MK; Mark MA; Cohen CJ
Gynecol Oncol; 1986 May; 24(1):41-50. PubMed ID: 3699576
[TBL] [Abstract][Full Text] [Related]
14. Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer.
Black D; Levine DA; Nicoll L; Chou JF; Iasonos A; Brown CL; Sonoda Y; Chi DS; Leitao MM; Abu-Rustum NR; Ferguson SE; Barakat RR
Gynecol Oncol; 2008 Apr; 109(1):39-42. PubMed ID: 18234300
[TBL] [Abstract][Full Text] [Related]
15. Consolidation intraperitoneal chemotherapy in epithelial ovarian cancer patients following negative second-look laparotomy.
Tarraza HM; Boyce CR; Smith WG; Jones MA
Gynecol Oncol; 1993 Sep; 50(3):287-90. PubMed ID: 8406188
[TBL] [Abstract][Full Text] [Related]
16. Does modality of adjuvant chemotherapy after interval surgical debulking matter in epithelial ovarian cancer?: An exploratory analysis.
Al Mutairi NJ; Le T
Int J Gynecol Cancer; 2014 Mar; 24(3):461-7. PubMed ID: 24442004
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy by the intravenous and intraperitoneal routes combined in ovarian cancer.
Zylberberg B; Ravina JH; Salat-Baroux J; Madelenat P; Zarca D; Dormont D
Gynecol Oncol; 1990 Feb; 36(2):271-6. PubMed ID: 2298416
[TBL] [Abstract][Full Text] [Related]
18. Tenckhoff catheter cytology in patients with ovarian cancer.
Geisinger KR; Ng LW; Hopkins MB; Barrett RJ; Welander CE; Homesley HD
Cancer; 1988 Oct; 62(8):1582-5. PubMed ID: 3167772
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
20. Technical considerations in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter.
Jenkins J; Sugarbaker PH; Gianola FJ; Myers CE
Surg Gynecol Obstet; 1982 Jun; 154(6):858-62. PubMed ID: 7079929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
